Rocket Pharmaceuticals Inc.
Organization details
- Legal name
- Rocket Pharmaceuticals Inc.
- Former names
- Inotek Pharmaceuticals Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RCKT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001281895
Board of directors
-
Carsten Boess · DirectorSince 2023
-
David P. Southwell · DirectorSince 2023
-
Elisabeth Bjork · DirectorSince 2023
-
Fady Ibraham Malik · DirectorSince 2023
-
Gaurav Shah · Director · CEOSince 2023
-
Gotham Makker · DirectorSince 2023
-
Keith Woods · DirectorSince 2023
-
Mikael Dolsten · DirectorSince 2024
-
Naveen Yalamanchi · DirectorSince 2023
-
Pedro P. Granadillo · DirectorSince 2023
-
Peter Fong · DirectorSince 2025
-
Piratip Pratumsuwan · DirectorSince 2025
-
Roderick Wong · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 20, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
68.2%
-
94.0%
-
98.1%
-
99.1%
-
99.1%
-
99.2%
-
99.3%
Board connections
6 of this board's directors also sit on 8 other boards. 7 are in the same sector.
-
TScan Therapeutics Inc. Same sectorvia David P. Southwell and Keith Woods
- via Mikael Dolsten
-
Atrium Therapeutics Inc. Same sectorvia Carsten Boess
-
Neurogene Inc. Same sectorvia Keith Woods
-
Orchestra BioMed Holdings Inc. Same sectorvia Roderick Wong
-
PTC Therapeutics Inc. Same sectorvia David P. Southwell
-
Pharvaris N.V. Same sectorvia Elisabeth Bjork
-
X4 Pharmaceuticals Inc. Same sectorvia Keith Woods
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $34,400
- 1 purchase by 1 insider
- Sold, last 12 months
- $991,822
- 26 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Wilson Martin Officer (General Counsel) | Open-market sale | −53,389 | $2.39 | $127,813 |
| Sep 11, 2026 | Wilson Martin Officer (General Counsel) | Open-market sale | −75,364 | $3.40 | $256,238 |
| Aug 18, 2026 | Gaurav Shah Officer (CEO) | Open-market sale | −2,293 | $3.38 | $7,750 |
| Aug 18, 2026 | Wilson Martin Officer (General Counsel) | Open-market sale | −631 | $3.38 | $2,133 |
| Aug 13, 2026 | Wilson Martin Officer (General Counsel) | Open-market sale | −3,493 | $3.38 | $11,806 |
| Aug 13, 2026 | Gaurav Shah Officer (CEO) | Open-market sale | −2,837 | $3.38 | $9,589 |
| Aug 11, 2026 | Chaudhuri Sarbani Officer (See Remarks) | Open-market sale | −4,701 | $3.50 | $16,454 |
| Aug 11, 2026 | Stevens Christopher James Officer (Chief Operating Officer) | Open-market sale | −36,658 | $3.50 | $128,303 |
| Aug 3, 2026 | David P. Southwell Director | Other | +150,000 | — | — |
| Aug 3, 2026 | Stevens Christopher James Officer (Chief Operating Officer) | Grant or award | +73,313 | — | — |
| Jun 18, 2026 | Carsten Boess Director | Grant or award | +22,862 | — | — |
| Jun 18, 2026 | Mikael Dolsten Director | Grant or award | +22,862 | — | — |
| Jun 18, 2026 | Peter Fong Director | Grant or award | +22,862 | — | — |
| Jun 18, 2026 | Fady Ibraham Malik Director | Grant or award | +22,862 | — | — |
| Jun 18, 2026 | David P. Southwell Director | Grant or award | +22,862 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Rocket Pharmaceuticals Inc.
Who is the CEO of Rocket Pharmaceuticals Inc.?
Gaurav Shah is Rocket Pharmaceuticals Inc.'s CEO.
How many directors are on Rocket Pharmaceuticals Inc.'s board?
Rocket Pharmaceuticals Inc.'s board has 13 directors: Carsten Boess, David P. Southwell, Elisabeth Bjork, Fady Ibraham Malik, Gaurav Shah, Gotham Makker, Keith Woods, Mikael Dolsten, Naveen Yalamanchi, Pedro P. Granadillo and 3 others.
Are Rocket Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Rocket Pharmaceuticals Inc. insiders bought $34,400 of shares in 1 purchase and sold $991,822 of shares in 26 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="rocket-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.